Header Logo

Connection

Bibi Maryam to Pharmacovigilance

Back to Details
This is a "connection" page, showing publications Bibi Maryam has written about Pharmacovigilance.
Bibi Maryam
Connection Strength
0.060
Pharmacovigilance
  1. Pregnancy-Related Adverse Events with Tyrosine Kinase Inhibitor Use in Chronic Myeloid Leukemia: A FAERS Pharmacovigilance Analysis (2001-2024). Clin Lymphoma Myeloma Leuk. 2026 Feb; 26(2):e229-e232.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.